LBP and atherosclerosis: LPS activates immune cells via LPS-binding protein (LBP)/soluble CD14 (sCD14)/toll-like receptor-4 (TRL4) signalling and has been implicated in the etiology of atherosclerosis among other inflammatory conditions [1, 2].